BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on the announcement.

America's Car-Mart reported a substantial increase in earnings per share for the fourth quarter, exceeding market ...

Boeing shares plummeted 7.45% in premarket trading following news of an Air India Boeing 787 Dreamliner crash.